| Ticker Symbol | Entity Name | Employer Id | As Of Date | Profile Url | Name | Website | Company Type | Industry | Active Status | Employer Status | Headquarters City | Year Founded | Rating: Overall | Rating: CEO (%) | Rating: Business Outlook (%) | Rating: Recommend (%) | Rating: Compensation & Benefits | Rating: Culture & Values | Rating: Career Opportunities | Rating: Diversity and Inclusion | Rating: Work/Life Balance | Rating: Senior Management | Ratings Star 1 Count | Ratings Star 2 Count | Ratings Star 3 Count | Ratings Star 4 Count | Ratings Star 5 Count | Ratings Count | Ratings Diversity and Inclusion Count | Ratings CEO Count | Ratings Star 1 (%) | Ratings Star 2 (%) | Ratings Star 3 (%) | Ratings Star 4 (%) | Ratings Star 5 (%) | Awards Count | Job Count | Review Count | Interview Experience: Positive | Interview Experience: Neutral | Interview Experience: Negative | Interview Channel: Online (%) | Interview Channel: Campus Recruiting | Interview Channel: Recruiter | Interview Channel: Employee Referral | Interview Channel: Staffing Agency | Interview Channel: In-Person | Interview Channel: Other | CEO Profile Image | CEO | Date Added | Date Updated | Company Name | Sector | Industry | CEO Gender | CEO Ethnicity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:supn | https://www.glassdoor.com?employer_id=536714 | 536714 | Apr 28th, 2024 12:00AM | Open | Supernus Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Rockville, MD | 3.60 | 95% | 59% | 61% | 3.40 | 3.70 | 3.60 | 3.80 | 3.70 | 3.10 | 7.00 | 9.00 | 11.00 | 17.00 | 19.00 | 63.00 | 74.00 | 77.00 | 11.111% | 14.286% | 17.46% | 26.984% | 30.159% | 0.00 | 125.00 | 0.43 | 0.09 | 0.48 | 0.38 | 0.56 | 0.06 | Jack A. Khattar | Apr 28th, 2024 04:25PM | Apr 28th, 2024 04:25PM | Supernus Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |||||||||||
| nasdaq:supn | https://www.glassdoor.com?employer_id=1326443 | 1326443 | Apr 28th, 2024 12:00AM | Open | Adamas Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Emeryville, CA | 2000 | 3.90 | 87% | 49% | 66% | 3.90 | 3.90 | 3.20 | 3.90 | 4.00 | 3.70 | 3.00 | 1.00 | 4.00 | 7.00 | 8.00 | 75% | 25% | 0.00 | 0.00 | 23.00 | 0.50 | 0.50 | 1.00 | Open | Neil McFarlane | Apr 28th, 2024 04:05PM | Apr 28th, 2024 04:25PM | Supernus Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||||||
| nasdaq:supn | https://www.glassdoor.com?employer_id=536714 | 536714 | Apr 26th, 2024 12:00AM | Open | Supernus Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Rockville, MD | 3.60 | 95% | 59% | 61% | 3.40 | 3.70 | 3.60 | 3.80 | 3.70 | 3.10 | 7.00 | 8.00 | 11.00 | 17.00 | 19.00 | 62.00 | 74.00 | 77.00 | 11.29% | 12.903% | 17.742% | 27.419% | 30.645% | 0.00 | 124.00 | 0.43 | 0.09 | 0.48 | 0.38 | 0.56 | 0.06 | Jack A. Khattar | Apr 26th, 2024 08:11AM | Apr 26th, 2024 08:11AM | Supernus Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |||||||||||
| nasdaq:supn | https://www.glassdoor.com?employer_id=1326443 | 1326443 | Apr 26th, 2024 12:00AM | Open | Adamas Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Emeryville, CA | 2000 | 3.90 | 87% | 49% | 66% | 3.90 | 3.90 | 3.20 | 3.90 | 4.00 | 3.70 | 3.00 | 1.00 | 4.00 | 7.00 | 8.00 | 75% | 25% | 0.00 | 0.00 | 23.00 | 0.50 | 0.50 | 1.00 | Open | Neil McFarlane | Apr 26th, 2024 07:51AM | Apr 26th, 2024 08:11AM | Supernus Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||||||
| nasdaq:supn | https://www.glassdoor.com?employer_id=536714 | 536714 | Apr 25th, 2024 12:00AM | Open | Supernus Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Rockville, MD | 3.60 | 95% | 59% | 61% | 3.40 | 3.70 | 3.60 | 3.80 | 3.70 | 3.10 | 7.00 | 8.00 | 11.00 | 17.00 | 19.00 | 62.00 | 74.00 | 77.00 | 11.29% | 12.903% | 17.742% | 27.419% | 30.645% | 0.00 | 124.00 | 0.43 | 0.09 | 0.48 | 0.38 | 0.56 | 0.06 | Jack A. Khattar | Apr 25th, 2024 06:33PM | Apr 25th, 2024 06:33PM | Supernus Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |||||||||||
| nasdaq:supn | https://www.glassdoor.com?employer_id=1326443 | 1326443 | Apr 25th, 2024 12:00AM | Open | Adamas Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Emeryville, CA | 2000 | 3.90 | 87% | 49% | 66% | 3.90 | 3.90 | 3.20 | 3.90 | 4.00 | 3.70 | 3.00 | 1.00 | 4.00 | 7.00 | 8.00 | 75% | 25% | 0.00 | 0.00 | 23.00 | 0.50 | 0.50 | 1.00 | Open | Neil McFarlane | Apr 25th, 2024 06:07PM | Apr 25th, 2024 06:33PM | Supernus Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||||||
| nasdaq:supn | https://www.glassdoor.com?employer_id=1326443 | 1326443 | Apr 24th, 2024 12:00AM | Open | Adamas Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Emeryville, CA | 2000 | 3.90 | 87% | 49% | 66% | 3.90 | 3.90 | 3.20 | 3.90 | 4.00 | 3.70 | 3.00 | 1.00 | 4.00 | 7.00 | 8.00 | 75% | 25% | 0.00 | 0.00 | 23.00 | 0.50 | 0.50 | 1.00 | Open | Neil McFarlane | Apr 24th, 2024 10:34AM | Apr 24th, 2024 10:57AM | Supernus Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||||||
| nasdaq:supn | https://www.glassdoor.com?employer_id=536714 | 536714 | Apr 24th, 2024 12:00AM | Open | Supernus Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Rockville, MD | 3.60 | 95% | 59% | 61% | 3.40 | 3.70 | 3.60 | 3.80 | 3.70 | 3.10 | 7.00 | 8.00 | 11.00 | 17.00 | 19.00 | 62.00 | 74.00 | 77.00 | 11.29% | 12.903% | 17.742% | 27.419% | 30.645% | 0.00 | 124.00 | 0.43 | 0.09 | 0.48 | 0.38 | 0.56 | 0.06 | Jack A. Khattar | Apr 24th, 2024 10:57AM | Apr 24th, 2024 10:57AM | Supernus Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |||||||||||
| nasdaq:supn | https://www.glassdoor.com?employer_id=536714 | 536714 | Apr 23rd, 2024 12:00AM | Open | Supernus Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Rockville, MD | 3.60 | 95% | 59% | 61% | 3.40 | 3.70 | 3.60 | 3.80 | 3.70 | 3.10 | 7.00 | 8.00 | 11.00 | 17.00 | 19.00 | 62.00 | 74.00 | 77.00 | 11.29% | 12.903% | 17.742% | 27.419% | 30.645% | 0.00 | 124.00 | 0.43 | 0.09 | 0.48 | 0.38 | 0.56 | 0.06 | Jack A. Khattar | Apr 23rd, 2024 04:30PM | Apr 23rd, 2024 04:30PM | Supernus Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |||||||||||
| nasdaq:supn | https://www.glassdoor.com?employer_id=1326443 | 1326443 | Apr 23rd, 2024 12:00AM | Open | Adamas Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Emeryville, CA | 2000 | 3.90 | 87% | 49% | 66% | 3.90 | 3.90 | 3.20 | 3.90 | 4.00 | 3.70 | 3.00 | 1.00 | 4.00 | 7.00 | 8.00 | 75% | 25% | 0.00 | 0.00 | 23.00 | 0.50 | 0.50 | 1.00 | Open | Neil McFarlane | Apr 23rd, 2024 04:08PM | Apr 23rd, 2024 04:30PM | Supernus Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology |